Finding drugs against CD133+ glioma subpopulations

J Neurosurg. 2011 Mar;114(3):648; discussion 648-50. doi: 10.3171/2009.11.JNS091668. Epub 2010 Nov 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • AC133 Antigen
  • Antigens, CD / metabolism*
  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / metabolism*
  • Celecoxib
  • Combined Modality Therapy
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Glioma / drug therapy*
  • Glioma / metabolism*
  • Glycoproteins / metabolism*
  • Humans
  • Neoplastic Stem Cells / pathology
  • Peptides / metabolism*
  • Precision Medicine
  • Pyrazoles / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • AC133 Antigen
  • Antigens, CD
  • Antineoplastic Agents
  • Cyclooxygenase 2 Inhibitors
  • Glycoproteins
  • PROM1 protein, human
  • Peptides
  • Pyrazoles
  • Sulfonamides
  • Celecoxib